EP1606044A1 - Dispositif et procede de production continue d'emulsions ou de dispersions - Google Patents

Dispositif et procede de production continue d'emulsions ou de dispersions

Info

Publication number
EP1606044A1
EP1606044A1 EP03816337A EP03816337A EP1606044A1 EP 1606044 A1 EP1606044 A1 EP 1606044A1 EP 03816337 A EP03816337 A EP 03816337A EP 03816337 A EP03816337 A EP 03816337A EP 1606044 A1 EP1606044 A1 EP 1606044A1
Authority
EP
European Patent Office
Prior art keywords
mixing vessel
emulsion
emulsions
dispersions
dispersion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP03816337A
Other languages
German (de)
English (en)
Other versions
EP1606044B2 (fr
EP1606044B1 (fr
Inventor
Gerd Dahms
Helmut Hegmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemira Oyj
Original Assignee
IFAC GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33016801&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1606044(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by IFAC GmbH and Co KG filed Critical IFAC GmbH and Co KG
Priority to EP03816337A priority Critical patent/EP1606044B2/fr
Priority to EP06015110.7A priority patent/EP1707256B1/fr
Publication of EP1606044A1 publication Critical patent/EP1606044A1/fr
Application granted granted Critical
Publication of EP1606044B1 publication Critical patent/EP1606044B1/fr
Publication of EP1606044B2 publication Critical patent/EP1606044B2/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/43—Mixing liquids with liquids; Emulsifying using driven stirrers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/50—Mixing liquids with solids
    • B01F23/53—Mixing liquids with solids using driven stirrers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/50—Pipe mixers, i.e. mixers wherein the materials to be mixed flow continuously through pipes, e.g. column mixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/20—Measuring; Control or regulation
    • B01F35/21—Measuring
    • B01F35/213—Measuring of the properties of the mixtures, e.g. temperature, density or colour

Definitions

  • the invention relates to a device and a method for the continuous production of emulsions or dispersions, in particular for the production of nanoemulsions.
  • Emulsions and dispersions are generally produced batchwise in stirred reactors.
  • the required amounts of the feed materials are metered into a mixing vessel and emulsified or dispersed with high stirring input.
  • high-speed stirrers are used, which allow the generation of cavitation forces.
  • high-pressure homogenization is carried out.
  • the emulsions and dispersions produced and the process are generally only checked on the finished product of the corresponding mixture batch. A continuous review of the manufacturing process is usually not possible.
  • the amount of product can only be varied to a very limited extent, since the possible batch size for a batch mixer is in a very limited range. As a rule, the minimum batch size must not be less than half the maximum batch size.
  • a batch process is also problematic with regard to sterile processing. As a rule, work is carried out in open stirred tanks, so that contamination from the outside cannot be ruled out. If work is to be carried out in the absence of air, a complex process for evacuating the mixing vessels is necessary for working under vacuum.
  • discontinuous mixing devices have to be designed large in order to be able to produce suitable product quantities. This is associated with considerable investment costs.
  • the high stirring input leads to high energy costs.
  • Large-scale manufacturing processes have so far been lacking, in particular in the production of nanoemulsions, especially solid lipid nano particles (SLN). For this reason, SLNs have so far not been able to gain widespread acceptance.
  • SLN dispersions are usually produced by high-pressure homogenization. Depending on the lipid and surfactant used, different particle shapes are obtained. A distinction is made between hot homogenization and cold homogenization. After melting the lipid and dissolving or dispersing the active ingredient, the hot homogenization is followed by dispersion in hot surfactant solution.
  • a high-pressure homogenization of this pre-emulsion is then carried out, which is then transferred into a hot O / W nanoemulsion.
  • solid lipid nanoparticles SSN
  • SSN solid lipid nanoparticles
  • the drug-lipid mixture solidifies and is then ground into microparticles.
  • the particles are then suspended in cold surfactant solution and high pressure homogenization of the particle suspension is carried out. The cavitation and shear forces that occur during high pressure homogenization are sufficiently large to break the lipid microparticles into lipid nanoparticles.
  • the pre-emulsion is usually homogenized in a piston-gap homogenizer at pressures between 200 bar and a maximum of 1500 bar in the hot state. This creates an emulsion whose lipid phase recrystallizes to SLN when cooled.
  • a piston-gap homogenizer at pressures between 200 bar and a maximum of 1500 bar in the hot state. This creates an emulsion whose lipid phase recrystallizes to SLN when cooled.
  • the SLN technology is used in particular for the application of pharmaceutical, cosmetic and / or food technology active ingredients in a solid carrier.
  • the active substance carrier can be adapted to the respective application and allows a suitable dosage and release of the active substance.
  • the SLN provide an alternative
  • the nanoparticles can contain hydrophilic or hydrophobic pharmaceutical active ingredients and can be administered orally or parenterally.
  • the matrix material used is
  • Emulsions used a solid lipid. To ensure high bio-acceptance and good in-vivo degradability, predominantly physiologically compatible lipids or
  • Lipids from physiological components such as glycerides from the body's own fatty acids are used.
  • emulsifiers or surfactants are usually used in the production.
  • a method for producing SLN dispersions is described, for example, in EP-B-0 167 825.
  • the lipid nano pellets are produced by dispersing the melted lipid with water using a high-speed stirrer.
  • the desired particle size distribution is then set by an ultrasound treatment. Stirring is usually at speeds ranging from 20 000 min: "1.
  • the object of the present invention is to provide a continuous, uncomplicated process for the preparation of emulsions and dispersions, which in particular allows the production of nanoemulsions with a controlled particle size.
  • the device and the method are intended to allow in-process / online quality control.
  • the production is to be simplified and accelerated compared to conventional batch processes. It should also be possible to produce variable amounts of emulsions or dispersions. In addition, it should be possible to work free of air.
  • a device for the continuous production of emulsions or dispersions with exclusion of air comprising a mixing vessel which is closed on all sides and which has supply and discharge pipes for the introduction and discharge of flowable substances or mixtures of substances and a stirring tool which has a stirring entry into the emulsion or dispersion without generating cavitation forces and without high pressure homogenization.
  • the object is achieved according to the invention by a process for the continuous production of emulsions and dispersions with exclusion of air, in which at least two flowable streams of at least two phases of the emulsions or dispersions are metered continuously continuously into a mixing vessel which is closed on all sides and in which they are stirred into an emulsion or dispersion are transferred, and the emulsion / dispersion is continuously discharged from the mixing vessel, the stirring being carried out without generating cavitation forces and without high-pressure homo-curing.
  • the mixing vessel is closed on all sides. This means that apart from feeds and discharges, as well as feedthroughs or feedthroughs for analytical sensors, the mixing vessel is closed. If both the feed and filling pipes are filled with flowable substances and the stirring tool and possibly analytical sensors are available, the mixing vessel is sealed against the entry of air or oxygen. This design of the mixing vessel is recorded under the expression "closed on all sides”.
  • the stirring tool allows mechanical stirring into the emulsion or dispersion without generating cavitation forces and without high pressure homogenization.
  • stirring tools In preferred stirring tools, suitable stirring elements are arranged on a stirrer shaft that is rotated.
  • the stirring tool can be a so-called
  • the housing which can be equipped with internals such as breakers, is generally used as the stator.
  • internals such as breakers
  • paddle stirrers come into consideration as stirrers, optionally with
  • Wipers can be provided.
  • kneaders and other suitable ones can be provided.
  • Stirrers such as planetary stirrers, anchor stirrers, bar stirrers, propellers, blade stirrers, dissolver disks or Intermig are used. Further suitable stirrer configurations are known to the person skilled in the art.
  • the stirring tool is operated so that the stirring entry into the emulsion or dispersion takes place without generation of cavitation forces and without high pressure homogenization.
  • u Mixing vessel may also have grinding tools such as grinding beads or balls. Suitable grinding tools are known to the person skilled in the art.
  • the mixing vessel can have any suitable geometry, as long as it permits a suitable mixing of the flowable substances or substance mixtures or the phases of the emulsions and dispersions to be produced. Suitable geometries are known to the person skilled in the art.
  • the mixing vessel preferably has a substantially cylindrical shape, the axis of the stirring tool lying in the cylinder axis and the feed and discharge pipes being arranged substantially perpendicular to the cylinder axis in the upper and lower peripheral region of the cylinder.
  • the feed and discharge pipes are thus, viewed along the cylinder axis, arranged as far apart as possible in positions along the cylinder circumference. They are arranged essentially perpendicular to the cylinder axis.
  • Deviations of ⁇ 10 °, preferably ⁇ 5 ° are possible.
  • the arrangement can be adapted to practical requirements.
  • the flowable substances or mixtures of substances are preferably introduced into the first mixing vessel separately or J-U guided.
  • the corresponding feed pipes preferably protrude somewhat into the mixing vessel. It is also possible to provide a premixing stage for the flowable substances or substance mixtures.
  • the individual components of the oil phase and the individual components of the water phase can be premixed separately. It is also possible for the oil phase and the water phase to be brought together in a premixing stage and to be introduced together into the mixing vessel.
  • the oil phase and the water phase or corresponding other phases are fed separately into the mixing vessel.
  • One or more supply and discharge pipes can be provided.
  • two or more, in particular two or three feed pipes and a discharge pipe are provided.
  • the size of the mixing vessel can be selected according to the respective practical requirements.
  • the internal volume (free volume) of the mixing vessel is preferably 2 to 70 ml, particularly preferably 3 to 50 ml, in particular 5 to 15 ml.
  • the internal volume is preferably 70 to 500 ml, particularly preferably 100 to 400 ml
  • the scale is preferably more than 500 ml, for example 500 to 50,000 ml.
  • mixing vessels with a volume of about 7 ml can be used, which have a cylindrical shape and an inner diameter of 20 mm and an inner height of 25 mm.
  • the internal volume can also be controlled by the thickness or the diameter of the rotor axis. It is also possible that configurations corresponding to an annular chamber reactor are obtained.
  • the residence times in the first mixing vessel are preferably 2 to 600 seconds, particularly preferably 4 to 100 seconds, in particular 8 to 40 seconds.
  • the invention it is possible according to the invention. to produce the desired emulsions and dispersions continuously with a mixing vessel.
  • a mixing vessel At least two mixing vessels are preferably connected in series, the discharge from the first mixing vessel being entered into the second mixing vessel and a further feed pipe being provided in the second mixing vessel.
  • the second (and subsequent) mixing vessel also has an agitator, as described. Accordingly, it is also possible to provide longer cascades of mixing vessels, the discharge of one mixing vessel being passed to the next mixing vessel and any further entries in the further mixing vessel can be entered. It is preferable to work with two or three, in particular with two mixing vessels connected in series.
  • thermocontrol can be achieved by cooling or heating jackets or by integrating the mixing vessel into an oven or a cryostat. Suitable devices for heating / cooling or tempering the mixing vessels are known to the person skilled in the art.
  • the ratio of the inflows is set in the first mixing vessel in such a way that when mixing in the first mixing vessel one works in the viscoelastic or highly viscous elastic range.
  • the viscoelastic area denotes the area in which the viscoelastic liquids show non-Newtonian liquid behavior.
  • the dependence of the viscosity of an emulsion or dispersion on the volume fraction of the disperse phase usually corresponds to an exponential function.
  • the important viscoelastic range in which work is preferably carried out according to the invention is the range in which the viscosity increases very strongly with increasing volume fraction of the disperse phase.
  • the weight ratio of the phases is preferably in a range from 1:15 to 15: 1, preferably 1: 5 to 5: 1, preferably 1: 2 to 2: 1, in particular 1: 1.5 to 1.5 : 1 selected.
  • the weight fractions of the corresponding phases are preferably in this range.
  • the process is highly viscous in the first stage and low-viscosity in the subsequent second stage.
  • the setting of a finely divided emulsion or dispersion is achieved in the first reactor, while the dilution to the final concentration of the product takes place in the second mixing vessel. Since in this case an additional amount of at least one of the phases or a further phase is entered into the second mixing vessel, the dwell time in the second mixing vessel is correspondingly shorter if both mixing vessels have the same internal volume.
  • the microemulsion obtained when the phases are mixed can be understood as a system of two interpenetrating networks, so that the microemulsion exhibits single-phase behavior.
  • At least one sensor for continuous measurement of the temperature, conductivity and / or optical properties of the emulsion or dispersion is arranged in the discharge pipes of the mixing vessels or at least one discharge pipe of a mixing vessel.
  • a corresponding sensor is usually provided in the discharge pipe near the mixing vessel.
  • Suitable sensors for determining the electrical conductivity, the temperature or optical properties such as turbidity are known to the person skilled in the art.
  • a sight glass can also be provided, through which an optical or visual control of the clarity or turbidity of the emulsion / dispersion is possible.
  • Machine-assisted optical methods include laser light scattering and absorbance measurements.
  • Optical methods for determining the particle size in the emulsions or dispersions can also be used for process control. It is also possible to carry out viscosity measurements, for example according to Brookfield, for example in line. The visual / optical control can be carried out by suitable and trained personnel. It is also possible to determine the amount of energy entered by the stirrer. Here too, a reaction to deviations in the energy input can be rapid, since this can indicate a changed composition of the emulsion / dispersion. Overall, the continuous determination of one or more of the parameters mentioned allows continuous process control and continuous control of the composition of the emulsion or dispersion. This significantly improves or simplifies quality assurance during production. This is of great importance, especially for pharmaceutical products.
  • phase volume ratio is possible via the conductivity.
  • the process control is preferably carried out online, ie continuously during the manufacturing process. This makes it possible to react immediately to deviations in the composition of the emulsions or dispersions. If, for example, the volume flows of the phases used change, the mixing vessel changes Get phase volume ratio, which leads to a changed conductivity.
  • the conductivity for example, the setting of the volume flows can also be controlled in order to ensure constant volume flows.
  • the supply of the flowable substances and the stirring entry and, if appropriate, the temperature control of the mixing vessels are computer-controlled. All process parameters can thus be controlled and monitored via a central computer (computer). The measured values supplied by the sensors can also be fed to the computer and evaluated with the aid of a computer.
  • the different flowable substances are dosed, for example, by means of suitable pumps.
  • suitable pumps are known to the person skilled in the art. They are preferably independent of the back pressure and can be controlled in fine increments.
  • suitable pumps are gear pumps, peristalsis / peristaltic pumps and other suitable pumps.
  • the combination of these pumps with the mixing vessels used according to the invention enables the production of emulsions without bubbles and air. Access to air is made difficult or impossible in the entire path of the flowable substances, since all process steps are carried out in a closed system. This is a further advantage of the method according to the invention, it being possible to dispense with complex method steps such as evacuating the emulsions.
  • the device according to the invention can be operated at low pressure, in particular at a pressure in the range from 1 to 10 bar, particularly preferably 1 to 1.5 bar.
  • the process is carried out accordingly at a pressure in this range.
  • the mixing vessels and lines can be constructed from any suitable materials.
  • suitable inert materials are plastics, steels such as V2A or V4A steel or copper. Suitable materials are known to the person skilled in the art.
  • the device can be constructed on a modular basis from individual components. These individual components can be, for example, pirmas, mixing vessels, sensor elements, stirring motors, temperature control units and connecting elements. All pumps and agitator motors can be controlled via a central computer. The selection of the stirrer, the size of the mixing vessels and the feed streams is based on practical requirements and can be determined by simple preliminary tests. In the two-stage procedure in particular, it is possible to work in the first stage with high viscosity and in the second stage with low viscosity, which makes a large number of different emulsions or dispersions easily accessible.
  • thickeners can optionally be added to the individual phases or flowable substances or substance mixtures. This makes it possible in a simple manner to reach a suitable viscosity range which allows the production of finely divided emulsions and dispersions with little stirring input.
  • the advantages of the continuous compared to discontinuous processes according to the invention are numerous: the production of the emulsions or dispersions is significantly accelerated. For example, the production of 1 liter of an emulsion in a continuous batch process with heating, cooling and homogenizing takes at least about 1.5 hours. Here are no statements about the quality of the
  • Emulsions or dispersions possible.
  • the method according to the invention allows a corresponding production in a maximum of about 15 minutes, the emulsions or
  • Dispersions can be analyzed and controlled in the process (in-process
  • nanoemulsions with particle or droplet sizes in the range from 15 to 300 ⁇ m, maximum 1000 nm, is possible in a simple manner.
  • the amount of emulsifier used can be significantly reduced. It is often possible to work with less than half the usual amount of emulsifier.
  • the device according to the invention can be easily adapted to a large number of applications by selecting suitable stirring tools.
  • the device according to the invention can be cleaned in a simple and quick manner. If the emulsions or dispersions to be produced are changed, cleaning can also be dispensed with. In this case, the substances or streams used are varied according to the new product composition, and the first discharge amount from the mixing vessels is discarded. The change in the emulsion until the constant desired product composition is obtained can in turn be followed via the online process control.
  • the device according to the invention and the method according to the invention are applicable to a large number of emulsions or dispersions.
  • emulsions or multiple emulsions are produced according to the invention.
  • Examples are OW emulsions, WO emulsions, PO emulsions, multiple emulsions, LC gels, liposomes or pearlescent concentrates. Since work is carried out in an air-free manner, active substances which are sensitive to oxidation can be introduced into the emulsions in an advantageous manner.
  • the method according to the invention allows the production of highly viscous systems such as gels. Liposomes can also be made at low pressure. It is possible to produce emulsions, ointments, gels for all common pharmaceutical, cosmetic, food technology or detergent technology areas. Other areas of application are also accessible according to the invention. Nanoe ulsionen have emulsion droplets having an average diameter in the range of 5 nm to 1000 ', preferably 15 to 300 nm. In the production of two-phase emulsions, a finely divided primary emulsion is generally prepared in the first mixture under highly viscous conditions, which is diluted to the desired final concentration in the second mixing vessel with one of the two phases.
  • an OW emulsion can be produced in the first mixing vessel with high oil contents, the primary emulsion thus obtained being diluted to the desired final concentration in the second mixing vessel with the addition of water. With this procedure, the main part of the external phase is diluted in the second mixing device.
  • System-adapted speeds and stirring tools can be used.
  • the active substance and the active substance carrier based on lipid and at least one emulsifier which forms luminal stricctures can be used at a temperature above the melting or softening index of the active substance carrier be mixed.
  • a phase B is formed here.
  • This phase B can then be mixed with an aqueous phase A at a temperature above the melting or softening point of the active ingredient carrier.
  • This mixture is carried out, for example, in the first mixing vessel.
  • the mixed phase can then be diluted to the desired final concentration with an aqueous phase. This dilution can be carried out in the second mixing vessel.
  • Lipid-based particles are used as drug carrier particles. These include lipids and lipid-like structures.
  • suitable lipids are the mono-, di- and triglycerides of saturated straight-chain fatty acids with 12 to 30 carbon atoms, such as lauric acid, myristic acid, palmitic acid, stearic acid, arachic acid, behenic acid, lignoceric acid, cerotic acid, melesic acid, and their esters with other polyhydric alcohols such as ethylene glycol , Propylene glycol, mannitol, sorbitol, saturated fatty alcohols with 12 to 22 carbon atoms such as lauryl alcohol, myrestyl alcohol, cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, saturated wax alcohols with 24 to 30 carbon atoms such as lignoceryl alcohol, ceryl alcohol, cerotyl alcohol, myrizyl alcohol.
  • synthetic mono-, di- and triglycerides are used as individual substances or in the form of a mixture, for example in the form of a hard fat.
  • Glycerol trifatty acid esters are, for example, glycerol trilaurate, glycerol trimyristate, glycerol palmitate, glycerol tristearate or glycerol tribehenate.
  • Suitable waxes are, for example, cetylpahnitat and Gera alba (bleached wax, DAB 9).
  • Lipids which can also be used are polysaccharides with or in individual cases or polyalkyl acrylates, polyalkyl cyanoacrylates, polyalkyl vinyl pyrrolidones, acrylic polymers, polylactic acids or polylactides.
  • the amount of the active substance carrier particles, based on the total aqueous active substance carrier dispersion, is preferably 0.1 to 30% by weight, particularly preferably 1 to 10% by weight.
  • dispersion stabilizers can be used. For example, they can be used in amounts of 0.01 to 10% by weight, preferably 0.05 to 5% by weight.
  • Suitable substances are surfactants, in particular ethoxylated sorbitan fatty acid esters, block polymers and block copolymers (such as, for example, poloxamers and poloxamines), polyglycerol ethers and esters, lecithins of various origins (for example egg or soy lecithin), chemically modified lecithins (for example hydrogenated lecithin) as well Phospholipids and sphingolipids, mixtures of lecithins with phospholipids, sterols (for example cholesterol and cholesterol derivatives and stigmasterol), esters and ethers of sugars or sugar alcohols with fatty acids or fatty alcohols (for example sucrose monostearate), sterically stabilizing substances such as poloxamers and poloxamines (polyoxyethylene-polyethylenes block polymers), ethoxylated sorbitan fatty acid esters, ethoxylated mono- x ⁇ nd diglycerides, ethoxylated lipids
  • viscosity-increasing substances such as cellulose ethers and esters (for example methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, sodium carboxymethyl cellulose), polyvinyl derivatives such as polyvinyl alcohol, polyvinyl pyrrolidone, polyvinyl acetate, alginates, polyacrylates (for example carbopol), Xanthans and pectins.
  • cellulose ethers and esters for example methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, sodium carboxymethyl cellulose
  • polyvinyl derivatives such as polyvinyl alcohol, polyvinyl pyrrolidone, polyvinyl acetate, alginates, polyacrylates (for example carbopol), Xanthans and pectins.
  • aqueous solutions or mixtures of water with water-miscible liquids such as glycerol or polyethylene glycol can be used as the aqueous phase A.
  • additional components for the aqueous phase are, for example Mannose, glucose, fructose, xylose, trehalose, mannitol, sorbitol, xylitol or other polyols such as polyethylene glycol and electrolytes such as sodium chloride. These additional components can be used in an amount of 0.5 to 60, for example 1 to 30% by weight, based on the aqueous phase A.
  • viscosity-increasing substances or charge carriers can also be used, as described in EP-B-0 605 497.
  • Natural or synthetic products can be used as emulsifiers that form lamellar structures.
  • surfactant mixtures is also possible.
  • suitable emulsifiers are the physiological bile salts such as sodium cholate, sodium dehydrocholate, sodium deoxycholate, sodium glycocholate, sodium taurocholate.
  • Animal and vegetable phospholipids such as lecithins with their hydrogenated forms and polypeptides such as gelatin with their modified forms can also be used.
  • Suitable synthetic surface-active substances are the salts of sulfosuccinic acid esters, polyoxyethylene acid betan esters, acid betanate esters and sorbitan ethers, polyoxyethylene fatty alcohol ethers, polyoxyethylene stearic acid esters as well as corresponding mixture condensates of polyoxyethylene methpolyoxypropylene ethers, ethoxylated saturated glycerides, partial fatty acid glyceride and glycerides.
  • suitable surfactants are Biobase® EP and Ceralution® H.
  • emulsifiers are also glycerol esters, polyglycerol esters, sorbitan esters, sorbitol esters, fatty alcohols, propylene glycol esters, alkyl glucose esters, sugar esters, lecithin, silicone copolymers, wool wax and mixtures or derivatives thereof.
  • Glycerol esters, polyglycerol esters, alkoxylates and fatty alcohols and iso alcohols can be derived, for example, from castor fatty acid, 12-hydroxystearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, stearic acid, myristic acid, lauric acid and capric acid.
  • Suitable fatty acid alkoxylates are, in particular, the ethoxylates, propoxylates or mixed ethoxylates / propoxylates.
  • emulsifiers are also used to prepare the cosmetic emulsions according to the invention.
  • suitable emulsifiers are glycerol esters, polyglycerol esters, sorbitan esters, sorbitol esters, fatty alcohols, propylene glycol esters, Alkyl glucoside esters, sugar esters, lecithin, silicone copolymers, wool wax and their mixtures and derivatives.
  • Glycerol esters, polyglycerol esters, alkoxylates and fatty alcohols and iso alcohols can be derived, for example, from castor fatty acid, 12-hydroxystearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, stearic acid, myristic acid, mauric acid and capric acid.
  • succinates, amides or ethanolamides of the fatty acids can also be present.
  • Suitable fatty acid alkoxylates are, in particular, the ethoxylates, propoxylates or mixed ethoxylates / propoxylates.
  • emulsifiers can be used which form L_ ⁇ mel__rslJ ⁇ ikturen.
  • physiological bile salts such as sodium cholate, sodium dehydrocheolate, sodium deoxycheolate, sodium glycochealate, sodium taurochealate.
  • Animal and vegetable phospholipids such as lecithins with their hydrogenated forms and polypeptides such as gelatin with their modified forms can also be used.
  • Suitable synthetic surface-active substances are the salts of sulfosuccinic acid esters, polyoxyethylene ethane esters, acid ether esters and sorbitan ethers, polyoxyethylene fatty alcohol ethers, polyoxyethylene stearic acid esters and corresponding mixture condensates of polyoxyethylene methpolyoxipropylene ethers, ethoxylated and saturated polyglycide glycerides, and glycated glycides.
  • suitable surfactants are Biobase ® EP and Ceralution ® H.
  • Lipids and emulsifiers are preferably used in a weight ratio of 50: 1 to 2: 1, preferably 15: 1 to 30: 1.
  • the pharmaceutical, cosmetic and / or food technology active ingredients, based on phase B are preferably used in an amount of 0.1 to 80% by weight, particularly preferably 1 to 10% by weight.
  • active pharmaceutical ingredients that can be used, for example, in free form, as a salt, ester or ether:
  • Analgesics / anti-rheumatic drugs such as morphine, copdein, Pt tnid, fentanyl and fentanyl derivatives, leyomethadone, tramadol, diclofenac, ibuprofen, indomethacin, naproxen, piroxicam, penicillamine;
  • Antiallergics such as pheniramine, dimetinden, terfenadine, astemizole, loratidine, doxylamine, meclozin, b ⁇ tmipin, clemastine;
  • Antibiotics / chemotherapeutics such as polypeptide antibiotics such as colistin, polymyxin B, teicplanin, vancomycin; Malaria drugs such as quinine, halofantrine, mefloquine, chloroquine, antivirals such as ganciclovir, foscarnet, zidovudine, acyclovir and others such as
  • Antimetabolites such as cytarabine, fluorouracil, methotrexate, mercaptopurine, tioguanine, alkaloids such as vinblastine, vincristine, vindesine; Antibiotics such as aclarubicin, bleomycin, dactinomycin, daunorubicin, epimbicin, idarubicin, mitomycin, plicamycin, complexes of sub-group elements (for example Ti, Zr, V, Nb, Ta, Mo, W, Pt) such as carboplatin, cisplatin and metallocene compounds such as titanacrine dichloride am dacarbazin, Estramustin, Etoposid, Hydroxycarbamid, Mitoxynthron, Procarbazin, Temiposid Alkylamidophospholipide (described in JM Zeidler, F. Emling, W. Zimmermann and HJ Roth, Archiv der Pharmazie, 324 (1991), 687)
  • Ether lipids such as hexadecylphosphocholine, ilmofosin and analogues, described in R. Zeisig, D. Arndt and H. Brachwitz, Pharmazie 45 (1990), 809 to 818.
  • Suitable active substances are, for example, dichlorphenac, ibuprofen, acetylsalicylic acid, salicylic acid, erythromycin, ketoprofen, cortisone, glucocorticoids.
  • cosmetic active ingredients that are particularly sensitive to oxidation or hydrolysis, such as polyphenols.
  • Catechins such as epicatechin, epicatechin-3-gallate, epigallocatechin, epigallocatechin-3-gallate
  • flavonoids such as luteolin, apigenin, rutin, quercitin, fisetin, kaempherol, rhametin
  • isoflavones such as genistein, glycine, daidzein
  • Prunetin coumarins (such as daphnetin, umbelliferon), Emodin, Resveratrol, Oregonin.
  • Vitamins such as retinol, tocopherol, ascorbic acid, riboflavin, pyridoxine are suitable. Also suitable are total extracts from plants that. include the above molecules or classes of molecules.
  • the active ingredients are light protection filters. These can be in the form of organic light protection filters at room temperature (25 ° C) in liquid or solid form. Suitable light protection filters (UV filters) are, for example, compounds based on benzophenone, diphenyl cyanoacrylate or p-aminobenzoic acid.
  • organic light protection filters are octyl triazone, avobenzone, octyl methoxycinnamate, octyl salicylate, benzotriazole and triazine.
  • anti-dandruff active ingredients such as are usually present in cosmetic or pharmaceutical formulations are used as active ingredients.
  • An example of this is piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-dimethylpentyl) -2 (1H) -pyridone; preferably in
  • emulsions are hydrophilically coated micropigments, electrolytes, glycerin, polyethylene glycol, propylene glycol, barium sulfate, alcohols, waxes, metal soaps, magnesium stearate, petroleum jelly or other ingredients.
  • perfume ms, perfume oils or perfume flavors can also be added.
  • Suitable cosmetic active ingredients for example polyphenols and compounds derived therefrom.
  • Suitable vitamins are retinol, tocopherol, ascorbic acid, riboflavin and pyridoxine.
  • active ingredients for example, all oxidation-sensitive active ingredients such as tocopherol can be considered.
  • organic dyes are used as active substances or instead of active substances.
  • all known and suitable water-in-oil emulsions or oil-in-water emulsions can be produced.
  • the emulsifiers and other ingredients described can be used.
  • polyol-in-oil emulsions Any suitable polyols can be used here.
  • the proportions of the two main phases in the emulsions can be varied within wide limits. For example, 5 to 95% by weight, preferably 10 to 90% by weight, in particular 20 to 80% by weight, of the respective phases are present, the total amount giving 100% by weight.
  • the P / O emulsion described can also be emulsified in water or a water-in-oil emulsion.
  • the result is a polyol-in-oil-in-water emulsion (P / O / W emulsion) which contains at least one emulsion described and additionally at least one aqueous phase.
  • P / O / W emulsion polyol-in-oil-in-water emulsion
  • Such multiple emulsions can correspond in structure to the emulsions described in DE-A-43 41 113.
  • the weight ratio of the individual phases can be varied within a wide range.
  • the weight fraction of the P / O emulsion is preferably 0.01 to 80% by weight, particularly preferably 0.1 to 70% by weight, in particular 1 to 30% by weight. %, based on the total P / O / W emulsion.
  • the proportion of the P / O emulsion is preferably 0.01 to 60% by weight, particularly preferably 0.1 to 40% by weight, in particular 1 up to 30% by weight, based on the P / O / W emulsion ultimately obtained.
  • the oil content is preferably 1 to 80% by weight, particularly preferably 1 to 30% by weight, based on the O / W emulsion used.
  • a W / O emulsion can also be introduced, which leads to a W / O / W emulsion.
  • the individual phases of the emulsions can also have the usual ingredients known for the individual phases.
  • the individual phases can contain further pharmaceutical or cosmetic active ingredients that are soluble in these phases.
  • the aqueous phase can contain, for example, organic soluble light protection filters, hydrophilically coated micropigment, electrolytes, alcohols, etc. Some or all of the phases can also contain solids, which are preferably selected from pigments or micropigments, microspheres, silica gel and similar substances.
  • the oil phase can for example, organically modified gate minerals, hydrophobically coated (micro) pigments, organic oil-soluble light protection filters, oil-soluble cosmetic active ingredients, waxes, metal soaps such as magnesium stearate, petroleum jelly or mixtures thereof.
  • Titanium dioxide, zinc oxide and barium sulfate as well as wollastonite, kaolin, talc, Al 2 O 3 , bismuth oxychloride, micronized polyethylene, mica, ultramarine, eosin colors, azo dyes can be mentioned as (micro) pigments.
  • titanium dioxide or zinc oxide are used in cosmetics as light protection filters and can be applied to the skin in a particularly smooth and uniform manner by means of the emulsions according to the invention.
  • Ivfikro spheres or silica gel can be used as carriers for active ingredients, and waxes can be used, for example, as the basis for polishes.
  • the water phase can also contain glycerol, polyethylene glycol, propylene glycol, ethylene glycol and similar compounds and derivatives thereof.
  • aqueous solutions or mixtures of water with water-miscible liquids such as glycerol or polyethylene glycol can be used as the aqueous phase.
  • Electrolytes such as sodium chloride can also be present in the aqueous phase.
  • viscosity-increasing substances or charge carriers can also be used, as described in EP-B-0605 497.
  • phase A and phase B being fed into the first mixing vessel, the query and phase C then being fed into the second mixing vessel.
  • the percentages given relate to the weight.
  • Particle sizes and inner surfaces were determined using a particle size analyzer (PSA).
  • Miglyol 812 N Caprylic / capric 60.0% 60.0% triglycerides
  • Protelan LS 9011 Sodium Lauroyl Sarcosinate 0.40% Brij 35 P Nena Laureth-23 1.05% Hexylene Glycol Hexylene Glycol 1.50% Demin. Water 4.50% phase B: Woleekyd L3 alkyd resin 58.0% phase C: demin. Water 34.5% 100.0%
  • phase A Protelan LS 9011 Sodium Lauroyl Sarcosinate 0.38% Brij 35 P Nena Laureth-23 0.41% Brij 700 Steareth-100 0.41% demin. Water 6.00% phase B:
  • Phase B propylene glycol (0.5% propylene glycol 71.00
  • Phase A Protelan LS 9011 Sodium Lauroyl Sarcosinate 0.75% Brij 35 P Nena Laureth-23 1.30% Pricerine 9091 Glycerin 2.25% demin. Water 2.25% phase B: Cutina CP Cetyl palmitate 44.8% a-tocopherol tocopherol 11.2% phase C: demin. Water 37.5% 100.0%

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Colloid Chemistry (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
  • Cosmetics (AREA)
  • Accessories For Mixers (AREA)

Abstract

L'invention concerne un dispositif permettant la production continue d'émulsions ou de dispersions, sous exclusion d'air, qui comprend une cuve de mélange présentant des tuyaux d'amenée et d'évacuation, pour introduire et évacuer des substances ou des mélanges de substances coulant(e)s, ainsi qu'un outil agitateur, qui permet d'introduire un mouvement d'agitation dans l'émulsion ou la dispersion, sans produire de forces de cavitation et sans homogénéisation à haute pression.
EP03816337A 2003-03-21 2003-03-21 Dispositif et procede de production continue d'emulsions ou de dispersions Expired - Lifetime EP1606044B2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03816337A EP1606044B2 (fr) 2003-03-21 2003-03-21 Dispositif et procede de production continue d'emulsions ou de dispersions
EP06015110.7A EP1707256B1 (fr) 2003-03-21 2003-03-21 Appareil et procédé pour la production en continue d'émulsions ou de dispersions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03816337A EP1606044B2 (fr) 2003-03-21 2003-03-21 Dispositif et procede de production continue d'emulsions ou de dispersions
PCT/EP2003/002996 WO2004082817A1 (fr) 2003-03-21 2003-03-21 Dispositif et procede de production continue d'emulsions ou de dispersions

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP06015110.7A Division EP1707256B1 (fr) 2003-03-21 2003-03-21 Appareil et procédé pour la production en continue d'émulsions ou de dispersions
EP06015110.7 Division-Into 2006-07-20

Publications (3)

Publication Number Publication Date
EP1606044A1 true EP1606044A1 (fr) 2005-12-21
EP1606044B1 EP1606044B1 (fr) 2006-09-27
EP1606044B2 EP1606044B2 (fr) 2010-12-15

Family

ID=33016801

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03816337A Expired - Lifetime EP1606044B2 (fr) 2003-03-21 2003-03-21 Dispositif et procede de production continue d'emulsions ou de dispersions

Country Status (7)

Country Link
US (1) US7775704B2 (fr)
EP (1) EP1606044B2 (fr)
JP (1) JP4782426B2 (fr)
AU (1) AU2003226694B2 (fr)
CA (1) CA2519591C (fr)
DE (2) DE50305216D1 (fr)
WO (1) WO2004082817A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610835B2 (en) 2010-05-07 2020-04-07 Clariant International Ag Emulsification device for continuously producing emulsions and/or dispersions

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1929271A1 (fr) * 2005-09-28 2008-06-11 IFAC GmbH & CO. KG Dispositif de controle de processus en ligne lors de la production d'emulsions ou de dispersions
DE102005049765A1 (de) * 2005-10-18 2007-04-19 Forschungszentrum Jülich GmbH Verfahren zur Effizienzsteigerung von Tensiden, zur Aufweitung des Temperaturfensters, zur Unterdrückung lamellarer Mesophasen in Mikroemulsionen mittels Additiven, sowie Mikroemulsionen
DE102007005622A1 (de) 2007-01-31 2008-08-07 Hebold Mixing & More Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung einer Mischung aus wenigstens zwei fließfähigen Phasen
JP4945318B2 (ja) * 2007-05-25 2012-06-06 株式会社仲田コーティング 微細気泡発生装置
EP2196194B1 (fr) * 2007-09-10 2017-08-09 M Technique Co., Ltd. Procédé de production d'ingesta biologiques et ingesta biologiques obtenus par celui-ci
FI20085953L (fi) 2008-10-09 2010-04-10 Tikkurila Oy Puun kyllästys
FI20085952L (fi) 2008-10-09 2010-04-10 Tikkurila Oy Kyllästys
US20130045238A1 (en) * 2009-04-22 2013-02-21 Agency For Science, Technology And Research Emulsions for transdermal delivery
DE102009040454A1 (de) 2009-08-27 2011-03-24 Otc Verwaltungs Gmbh Herstellung von Perlglanzdispersionen
WO2011023803A2 (fr) 2009-08-27 2011-03-03 Otc Gmbh Concentré nacré et procédé de production
DE102011116069A1 (de) * 2011-10-18 2013-04-18 Dr. Rimpler Gmbh Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung
US9907758B2 (en) * 2012-01-09 2018-03-06 Panjab University Department Of Biotechnology (Dbt) Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
FR3000957A1 (fr) 2013-01-16 2014-07-18 Nitrates & Innovation Installation modulaire de fabrication d'un precurseur d'emulsion explosive
US10159949B2 (en) 2016-03-11 2018-12-25 Fujifilm Planar Solutions, LLC Advanced fluid processing methods and systems
CN105854680A (zh) * 2016-05-11 2016-08-17 范绍玉 一种机械工程用搅拌装置
US11583787B2 (en) 2017-07-20 2023-02-21 Clariant International Ltd Demulsifiers and a method of using demulsifiers for breaking emulsions of water and crude oil
CN114307756B (zh) * 2021-12-14 2022-12-27 湖州倍格曼新材料股份有限公司 一种基于丁达尔效应判断粘结剂胶凝状态的混合系统

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2361035A (en) * 1942-08-01 1944-10-24 Lummus Co Wax-oil separation
US2475191A (en) * 1947-01-30 1949-07-05 Gen Motors Corp Method for producing latex foam
US3062627A (en) * 1958-04-23 1962-11-06 Shell Oil Co Rotating disc contactor
US3579461A (en) * 1967-11-20 1971-05-18 Johnson & Son Inc S C Emulsification process
US3600328A (en) * 1968-12-10 1971-08-17 Union Oil Co Apparatus for forming emulsions
US3855368A (en) * 1972-04-26 1974-12-17 Ceskoslovenska Akademie Ved Apparatus for bringing fluid phases into mutual contact
US3951386A (en) * 1975-03-31 1976-04-20 Phillips Petroleum Company Uniform mixing in vessels
US4123403A (en) † 1977-06-27 1978-10-31 The Dow Chemical Company Continuous process for preparing aqueous polymer microsuspensions
JPS6049015B2 (ja) * 1978-12-18 1985-10-30 福嶋 唯夫 連続乳化装置
JPS5735826U (fr) * 1980-08-08 1982-02-25
US4403866A (en) * 1982-05-07 1983-09-13 E. I. Du Pont De Nemours And Company Process for making paints
JPS59203632A (ja) 1983-05-06 1984-11-17 Fuji Photo Film Co Ltd 乳化方法
DE3421468A1 (de) 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
CH674317A5 (fr) * 1988-01-29 1990-05-31 Applied Biosystems
US5149720A (en) * 1991-08-12 1992-09-22 The Procter & Gamble Company Process for preparing emulsions that are polymerizable to absorbent foam materials
US5250576A (en) * 1991-08-12 1993-10-05 The Procter & Gamble Company Process for preparing emulsions that are polymerizable to absorbent foam materials
DE4202212A1 (de) 1992-01-28 1993-07-29 Basf Ag Kontinuierliches verfahren zur herstellung von waessriger polyacrylat-sekundaerdispersionen
JP3306131B2 (ja) * 1992-11-05 2002-07-24 富士写真フイルム株式会社 マイクロカプセルの製造方法
JP2581530B2 (ja) * 1995-03-20 1997-02-12 インテヴェップ，エス．エイ． エマルジョン形成システム及び混合装置
EP0779321B1 (fr) * 1995-12-05 2003-08-06 Fuji Photo Film Co., Ltd. Procédé pour préparer une solution d'ester cellulosique
JPH09192466A (ja) * 1996-01-19 1997-07-29 Toppan Printing Co Ltd 湿式分散装置及びインキの製造方法
FR2747321B1 (fr) * 1996-04-16 1998-07-10 Centre Nat Rech Scient Procede de preparation d'une emulsion
DE19828741A1 (de) † 1998-06-27 1999-12-30 Leo Elektronenmikroskopie Gmbh Elektronenmikroskop mit einem abbildenden magnetischen Energiefilter
DE19828742A1 (de) 1998-06-27 1999-12-30 Basf Coatings Ag Taylorreaktor für Stoffumwandlungen, bei deren Verlauf einer Änderung der Viskosität v des Reaktionsmediums eintritt
FR2787326B1 (fr) 1998-12-17 2001-01-26 Oreal Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6120175A (en) * 1999-07-14 2000-09-19 The Porter Company/Mechanical Contractors Apparatus and method for controlled chemical blending
JP2002107868A (ja) * 2000-07-14 2002-04-10 Fuji Photo Film Co Ltd 脂肪酸銀塩の製造方法および熱現像画像記録材料
JP4451581B2 (ja) * 2001-09-28 2010-04-14 株式会社日本触媒 重合防止剤の作成供給装置および作成供給方法
JP3747174B2 (ja) * 2001-11-19 2006-02-22 株式会社カイジョー 半導体処理装置の薬液濃度制御装置
JP4588305B2 (ja) * 2003-08-13 2010-12-01 冷化工業株式会社 撹拌混合装置および殺菌装置および洗浄装置
KR100500475B1 (ko) * 2003-11-10 2005-07-12 삼성전자주식회사 케미컬 혼합장치

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004082817A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610835B2 (en) 2010-05-07 2020-04-07 Clariant International Ag Emulsification device for continuously producing emulsions and/or dispersions

Also Published As

Publication number Publication date
CA2519591C (fr) 2011-07-12
CA2519591A1 (fr) 2004-09-30
EP1606044B2 (fr) 2010-12-15
WO2004082817A1 (fr) 2004-09-30
JP4782426B2 (ja) 2011-09-28
EP1606044B1 (fr) 2006-09-27
DE50305216D1 (de) 2006-11-09
DE20321104U1 (de) 2006-01-05
US7775704B2 (en) 2010-08-17
US20070025177A1 (en) 2007-02-01
JP2006520678A (ja) 2006-09-14
AU2003226694A1 (en) 2004-10-11
AU2003226694B2 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
EP1606044B2 (fr) Dispositif et procede de production continue d'emulsions ou de dispersions
EP0605497B2 (fr) Excipient constitue de particules lipidiques solides dites nanospheres lipidiques solides (sln)
EP1868573B1 (fr) Procede de production de suspensions de l'ordre du micron ultrafines
EP0790821B1 (fr) Procede pour la preparation de nanosuspensions pharmaceutiques
EP1194123B1 (fr) Procede pour la production douce de microparticules et de nanoparticules extra-fines
DE10312763A1 (de) Verfahren zur Herstellung einer SLN-Dispersion
Zielińska et al. Solid lipid nanoparticles and nanostructured lipid carriers as novel carriers for cosmetic ingredients
EP1707256B1 (fr) Appareil et procédé pour la production en continue d'émulsions ou de dispersions
DE102005017777A1 (de) Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen
EP1929271A1 (fr) Dispositif de controle de processus en ligne lors de la production d'emulsions ou de dispersions
DE202005015341U1 (de) Vorrichtung zur In-Line-Prozesskontrolle bei der Herstellung von Emulsionen oder Dispersionen
KR20060004918A (ko) 에멀젼 또는 분산액을 연속적으로 제조하는 장치 및 방법
DE19945203A1 (de) Fest-flüssig (halbfeste) Lipidpartikel (Nano-Compartiment-Carrier-NCC) und Verfahren zur Herstellung hochkonzentrierter Lipidpartikel
US20220273582A1 (en) Continuous method for nano-emulsification by concentration phase inversion

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050929

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IFAC GMBH & CO. KG

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE FR GB

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KEMIRA PIGMENTS OY

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20060927

REF Corresponds to:

Ref document number: 50305216

Country of ref document: DE

Date of ref document: 20061109

Kind code of ref document: P

ET Fr: translation filed
PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

26 Opposition filed

Opponent name: BASF AKTIENGESELLSCHAFT

Effective date: 20070626

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

PLAF Information modified related to communication of a notice of opposition and request to file observations + time limit

Free format text: ORIGINAL CODE: EPIDOSCOBS2

PLAF Information modified related to communication of a notice of opposition and request to file observations + time limit

Free format text: ORIGINAL CODE: EPIDOSCOBS2

PLAF Information modified related to communication of a notice of opposition and request to file observations + time limit

Free format text: ORIGINAL CODE: EPIDOSCOBS2

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: BASF SE

Effective date: 20070626

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: KEMIRA OYJ

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20100212 AND 20100217

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20101215

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): DE FR GB

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210323

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210319

Year of fee payment: 19

Ref country code: GB

Payment date: 20210324

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 50305216

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: B01F0003080000

Ipc: B01F0023400000

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 50305216

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220321

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220321

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220331

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221001